Search Results - "RIEDERER, P"

Terahertz study of ambipolar transport in the semiconducting polymer poly-diketopyrrolopyrrole-terthiophene (PDPP3T) by Riederer, P., Eckel, C., Weitz, R. T., Kersting, R.

“…Terahertz electromodulation spectroscopy is used to investigate charge transport in the semiconducting polymer poly-diketopyrrolopyrrole-terthiophene (PDPP3T)…”
Get full text

Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals – a proof of concept study by Sheldrick, A., Camara, S., Ilieva, M., Riederer, P., Michel, T.M.

“…The neurotrophic factors (NTF) hypothesis of depression was postulated nearly a decade ago and is nowadays widely acknowledged. Previous reports suggest that…”
Get full text

Field-induced migration of gold in molecular semiconductors by Riederer, P., Bouraoui, M., Kersting, R.

“…We report on the degradation of field-effect devices due to the migration of gold from injection contacts into the channel region. The experimental results are…”
Get full text

Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease by Riederer, P., Monoranu, C., Strobel, S., Iordache, T., Sian-Hülsmann, J.

“…About 60 years ago, the discovery of a deficiency of dopamine in the nigro-striatal system led to a variety of symptomatic therapeutic strategies to supplement…”
Get full text

Impact of surface roughness on conduction in molecular semiconductors by Riederer, P., Bouraoui, M., Kersting, R.

“…The interface roughness between gate insulator and semiconductor is expected to reduce the conductance of molecular field-effect transistors. This study merges…”
Get full text

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 by Hiemke, C, Bergemann, N, Clement, H W, Conca, A, Deckert, J, Domschke, K, Eckermann, G, Egberts, K, Gerlach, M, Greiner, C, Gründer, G, Haen, E, Havemann-Reinecke, U, Hefner, G, Helmer, R, Janssen, G, Jaquenoud, E, Laux, G, Messer, T, Mössner, R, Müller, M J, Paulzen, M, Pfuhlmann, B, Riederer, P, Saria, A, Schoppek, B, Schoretsanitis, G, Schwarz, M, Gracia, M Silva, Stegmann, B, Steimer, W, Stingl, J C, Uhr, M, Ulrich, S, Unterecker, S, Waschgler, R, Zernig, G, Zurek, G, Baumann, P

“…Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the…”
Get more information

Lateralisation in Parkinson disease by Riederer, P., Jellinger, K. A., Kolber, P., Hipp, G., Sian-Hülsmann, J., Krüger, R.

“…Asymmetry of dopaminergic neurodegeneration and subsequent lateralisation of motor symptoms are distinctive features of Parkinson’s disease compared to other…”
Get full text

Molecular semiconductors and the Ioffe–Regel criterion: A terahertz study on band transport in DBTTT by Riederer, P., Devaux, F., Schweicher, G., Geerts, Y. H., Kersting, R.

“…Terahertz electromodulation spectroscopy provides insight into the physics of charge carrier transport in molecular semiconductors. The work focuses on…”
Get full text

Clinical applications of MAO-inhibitors by Riederer, P, Lachenmayer, L, Laux, G

“…Monoamine oxidase inhibitors (MAO-I) have been useful in the treatment of both psychiatric and neurological disorders over centuries. Here we focus on the…”
Get more information

45 years German Society of Biological Psychiatry (DGBP) by Riederer, P., Kircher, T., Juckel, G., Domschke, K., Schneider, A., Deckert, J., Falkai, P.

“…The foundation of a German Society of Biological Psychiatry (DGBP) was initiated at the Second World Congress of Biological Psychiatry of the WFSBP in…”
Get full text

Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease? by Knezovic, A., Loncar, A., Homolak, J., Smailovic, U., Osmanovic Barilar, J., Ganoci, L., Bozina, N., Riederer, P., Salkovic-Petrisic, Melita

“…Accumulated evidence suggests that the insulin-resistant brain state and cerebral glucose hypometabolism might be the cause, rather than the consequence, of…”
Get full text

The significance of neuronal lateralisation in Parkinson’s disease by Riederer, P., Sian-Hülsmann, J.

“…The destruction of the dopaminergic neurons in the substantia nigra (SN) and consequent depletion of striatal dopamine elicits the main movement deficits…”
Get full text

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry by Baumann, P, Hiemke, C, Ulrich, S, Eckermann, G, Gaertner, I, Gerlach, M, Kuss, H-J, Laux, G, Müller-Oerlinghausen, B, Rao, M L, Riederer, P, Zernig, G

“…Therapeutic Drug Monitoring (TDM) is a valid tool to optimise pharmacotherapy. It enables the clinician to adjust the dosage of drugs according to the…”
Get more information

Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease by Jacob, C P, Koutsilieri, E, Bartl, J, Neuen-Jacob, E, Arzberger, T, Zander, N, Ravid, R, Roggendorf, W, Riederer, P, Grünblatt, E

“…Excitatory neurotransmitter dysfunction has been discussed to be involved in the pathophysiology of Alzheimer's disease (AD). In the current study we…”
Get more information

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder by Mehler-Wex, C, Riederer, P, Gerlach, M

“…The basal ganglia form a forebrain system that collects signals from a large part of the neocortex, redistributes these cortical inputs both with respect to…”
Get full text

Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer’s disease progression: CX3CL1, TREM2, and PPARγ by Strobel, S., Grünblatt, E., Riederer, P., Heinsen, H., Arzberger, T., Al-Sarraj, S., Troakes, C., Ferrer, I., Monoranu, Camelia Maria

“…The role of neuroinflammation in the pathogenesis of neurodegenerative diseases has become more evident in recent years. Research on the etiology and…”
Get full text

Microglia activation is related to substantia nigra echogenicity by Berg, D., Godau, J., Riederer, P., Gerlach, M., Arzberger, T.

“…Hyperechogenicity of the substantia nigra (SN) is a sensitive marker for Parkinson’s disease (PD). Previously, a relation between SN echogenicity and iron as…”
Get full text

Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions by Unterecker, S., Riederer, P., Proft, F., Maloney, J., Deckert, J., Pfuhlmann, B.

“…Therapeutic drug monitoring (TDM) data of antidepressant drugs are often evaluated using homogeneous samples of selected individuals without psychiatric or…”
Get full text

Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease by Fedorow, H, Tribl, F, Halliday, G, Gerlach, M, Riederer, P, Double, K L

“…Neuromelanin (NM) is a dark polymer pigment produced in specific populations of catecholaminergic neurons in the brain. It appears in greatest quantities in…”
Get full text

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes by Grünblatt, E, Mandel, S, Jacob-Hirsch, J, Zeligson, S, Amariglo, N, Rechavi, G, Li, J, Ravid, R, Roggendorf, W, Riederer, P, Youdim, M B H

“…Gene expression profiling of human substantia nigra pars compacta (SNpc) from Parkinson's disease (PD) patients, was examined employing high density…”
Get full text